Trademark Overview
On Monday, May 19, 2014, a trademark application was filed for DRIVERS NEEDED with the United States Patent and Trademark Office. The USPTO has given the DRIVERS NEEDED trademark a serial number of 86285212. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, April 30, 2015. This trademark is owned by Synageva BioPharma Corp.. The DRIVERS NEEDED trademark is filed in the Advertising, Business and Retail Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
employment hiring, recruiting, staffing and career networking services; providing a web site featuring employment opportunities; providing employment information in the field of research, development, commercialization and distribution of pharmaceuticals and therapeutics; providing employment information in the field of rare, terminal and genetic diseases research, prevention, treatments, and patient care services; providing on-line employment information in the field of research, development, commercialization and distribution of pharmaceuticals and therapeutics; providing on-line employment information in the field of rare, terminal and genetic diseases research, prevention, treatments, and patient care services
scientific research and development concerning products and processes for the expression, evolution, screening, production and purification of proteins and other pharmaceutical compounds for research and industry; biological, pharmaceutical and medical research; medical and scientific research, namely, conducting clinical research; laboratory research services relating to pharmaceuticals; pharmaceutical drug development services; pharmaceutical research and development; scientific and technological services, namely, biological research and analysis; research and research services in the field of the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and transient expression of proteins; development and research of new products for others
providing information on rare, terminal and genetic diseases research, prevention, treatments, and patient care services; providing information on Lysosomal Acid Lipase Deficiency, research, prevention, treatments, and patient care services; providing information on research, design, commercialization and distribution of pharmaceuticals and therapeutics; providing a web site featuring information on rare, terminal and genetic diseases research, prevention, treatments, and patient care services; providing a web site featuring information on Lysosomal Acid Lipase Deficiency, research, prevention, treatments, and patient care services; providing a web site featuring information on research, development, commercialization and distribution of pharmaceuticals and therapeutics